HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A membrane transporter determines the spectrum of activity of a potent platinum-acridine hybrid anticancer agent.

Abstract
Cytotoxic drugs that are mechanistically distinct from current chemotherapies are attractive components of personalized combination regimens for combatting aggressive forms of cancer. To gain insight into the cellular mechanism of a potent platinum-acridine anticancer agent (compound 1), a correlation analysis of NCI-60 compound screening results and gene expression profiles was performed. A plasma membrane transporter, the solute carrier (SLC) human multidrug and toxin extrusion protein 1 (hMATE1, SLC47A1), emerged as the dominant predictor of cancer cell chemosensitivity to the hybrid agent (Pearson correlation analysis, p < 10-5) across a wide range of tissues of origin. The crucial role of hMATE1 was validated in lung adenocarcinoma cells (A549), which expresses high levels of the membrane transporter, using transporter inhibition assays and transient knockdown of the SLC47A1 gene, in conjunction with quantification of intracellular accumulation of compound 1 and cell viability screening. Preliminary data also show that HCT-116 colon cancer cells, in which hMATE1 is epigenetically repressed, can be sensitized to compound 1 by priming the cells with the drugs EPZ-6438 (tazemetostat) and EED226. Collectively, these results suggest that hMATE1 may have applications as a pan-cancer molecular marker to identify and target tumors that are likely to respond to platinum-acridines.
AuthorsXiyuan Yao, Noah H Watkins, Heather Brown-Harding, Ulrich Bierbach
JournalScientific reports (Sci Rep) Vol. 10 Issue 1 Pg. 15201 (09 16 2020) ISSN: 2045-2322 [Electronic] England
PMID32939009 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Acridines
  • Antineoplastic Agents
  • Benzamides
  • Biphenyl Compounds
  • EED226
  • Morpholines
  • Organic Cation Transport Proteins
  • Organoplatinum Compounds
  • Pyridones
  • SLC47A1 protein, human
  • Sulfones
  • Triazoles
  • Platinum
  • tazemetostat
  • Pyrimethamine
Topics
  • A549 Cells
  • Acridines (chemistry)
  • Antineoplastic Agents (chemistry, pharmacology)
  • Benzamides (pharmacology)
  • Biphenyl Compounds
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Drug Synergism
  • Epigenesis, Genetic (drug effects)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • HCT116 Cells
  • Humans
  • Molecular Structure
  • Morpholines
  • Organic Cation Transport Proteins (genetics)
  • Organoplatinum Compounds (chemistry, pharmacology)
  • Platinum (chemistry)
  • Pyridones (pharmacology)
  • Pyrimethamine (pharmacology)
  • Sulfones (pharmacology)
  • Triazoles (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: